0001214659-20-004864.txt : 20200520 0001214659-20-004864.hdr.sgml : 20200520 20200520171056 ACCESSION NUMBER: 0001214659-20-004864 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200518 FILED AS OF DATE: 20200520 DATE AS OF CHANGE: 20200520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CARTER BRUCE L A CENTRAL INDEX KEY: 0001225503 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35921 FILM NUMBER: 20898941 MAIL ADDRESS: STREET 1: C/O ZYMOGENETICS, INC. STREET 2: 1201 EASTLAKE AVENUE CITY: SEATTLE STATE: WA ZIP: 98102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirati Therapeutics, Inc. CENTRAL INDEX KEY: 0001576263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462693615 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-332-3410 MAIL ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 marketforms-48830.xml PRIMARY DOCUMENT X0306 4 2020-05-18 0001576263 Mirati Therapeutics, Inc. MRTX 0001225503 CARTER BRUCE L A C/O MIRATI THERAPEUTICS, INC 9393 TOWNE CENTRE DRIVE, STE 200 SAN DIEGO CA 92121 true false false false Common Stock 2020-05-18 4 M false 4000 6.78 A 6000 D Common Stock 2020-05-18 4 S false 4000 106.8601 D 2000 D Non-Qualified Stock Option (right to buy) 6.78 2020-05-18 4 M false 4000 0 D 2026-09-26 Common Stock 4000 9000 D All shares sold at an exact price. The shares subject to the Option vest and become exercisable in 36 equal monthly installments following the date of grant. /s/ Vickie Reed, Attorney-in-Fact 2020-05-20